CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A Pilot Trial of Low-Dose Intravenous Abciximab and Unfractionated Heparin for Acute Ischemic Stroke: Translating GP IIb/IIIa Receptor Inhibition to Clinical Practice
Author
A Bruno
A Furlan
+57Â more
Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
AH Ingall
AM Pancioli
Assessment of the Safety and Efficacy of a New Treatment Strategy with Percuataneous Coronary Intervention (ASSENT-4 PCI) Investigators
BS Coller
BS Coller
C Kleinschnitz
C Weimar
CL Dubois
DM Kent
E Lo
G Ding
G Torgano
HK Gold
HP Adams
J Phillipps
Jane A. Anderson
JC Grotta
K Uchino
KY Lee
M Ali
M Ribo
P Mandava
P Mandava
P Mandava
P Mandava
P Mandava
P Mandava
P Mandava
P Theroux
PC Wong
Perumal Thiagarajan
Pitchaiah Mandava
Raymond U. Weir
RJ Dachs
Roderic H. Fabian
RT Cheung
S Martin-Schild
SK Mehta
SK Samra
SR Martini
SR Steinhubl
SR Steinhubl
SR Steinhubl
T Abumiya
TF Choudhri
The Abciximab in Ischemic Stroke Investigators
The Epic Investigators
The Impact II investigators
The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group
Thomas A. Kent
TJ Ingall
W Hacke
W Hacke
W Hacke
William Dalmeida
Y Lampl
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref